Recurrent mutations refine prognosis in chronic lymphocytic leukemia
Leukemia2014Vol. 29(2), pp. 329–336
Citations Over TimeTop 1% of 2014 papers
Panagiotis Baliakas, Anastasia Hadzidimitriou, L-A Sutton, Davide Rossi, Eva Minga, Neus Villamor, Marta Larráyoz, Jana Kmínková, Andreas Agathangelidis, Zadie Davis, Eugen Tausch, Evangelia Stalika, Barbara Kantorová, Larry Mansouri, Lydia Scarfò, Diego Cortese, Veronika Navrkalová, Matthew Rose‐Zerilli, Karin E. Smedby, Gunnar Juliusson, Αchilles Anagnostopoulos, Antonis Makris, Alba Navarro, Julio Delgado, David Oscier, Chrysoula Belessi, Stephan Stilgenbauer, Paolo Ghia, Šárka Pospı́šilová, Gianluca Gaïdano, Elı́as Campo, Jonathan C. Strefford, Κώστας Σταματόπουλος, Richard Rosenquist
Related Papers
- → Expression of COBLL1 encoding novel ROR1 binding partner is robust predictor of survival in chronic lymphocytic leukemia(2017)27 cited
- → Clinical impact of MYD88 mutations in chronic lymphocytic leukemia(2016)9 cited
- → Total Proteome Analysis Identifies Migration Defects As a Major Pathogenetic Factor in IGHV-Unmutated Chronic Lymphocytic Leukemia(2014)3 cited
- High level of COBLL1, a novel ROR1 binding partner, identifies chronic lymphocytic leukemia (CLL) patients with mutated IghV(2014)
- Assessment of Novel Molecular Prognostic Markers in Chronic Lymphocytic Leukemia(2010)